The US patent, titled “Protective Compositions for Dermal Papilla Cells,” was issued on Aug. 21, 2012.
According to Sabinsa, headquartered in East Windsor, N.J., Saberry is a proprietary extract from the fruits of Emblica officinalis (Phyllanthus emblica), commonly called amla. The Saberry ingredient is a standardized extract using a β-glucogallin biomarker. Cococin, another patented ingredient, consists of freeze-dried coconut water solids manufactured by a proprietary lyophilisation technique. The company says Cococin contains no added sugars and carbohydrates, and it retains intact the nutritive value from the minerals, vitamins, amino acids and electrolyte content of coconut water.
The Saberry+Cococin product aims to protect dermal papilla cells, located in the scalp, from stress.
Dr. Muhammed Majeed, Founder and Chairman of the SAMI-SABINSA group said “It is a pleasure to note Sabinsa’s continued success in providing technological solutions in the alternative medicine sector, the latest being the combination of amla extract standardized with the biomarker β-glucogallin and Cococin™ for dermal papilla protection.”
According to Sabinsa, the new patent is the 75th in the company’s IP portfolio.